Intra-arterial chemotherapy for malignant gliomas: a critical analysis

Area of Science:

• Neuro-oncology
• Chemotherapy delivery systems
• Cancer stem cell research

Background:

• Malignant gliomas, including glioblastoma multiforme, have historically been treated with various chemotherapy methods.
• Intra-arterial (IA) chemotherapy delivery for these tumors has been explored for decades.
• Advances in endovascular techniques have refined IA delivery, but its superiority remains debated.

Purpose of the Study:

• To review the existing literature on IA chemotherapy for malignant gliomas.
• To assess the advantages and disadvantages of IA chemotherapy compared to intravenous (IV) and oral routes.
• To propose a hypothesis for utilizing IA delivery to target cancer stem cells in their niche.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies on IA chemotherapy for malignant gliomas.
• Analysis of safety and efficacy data for IA versus IV and oral chemotherapy.
• Exploration of endovascular devices and techniques in IA therapy.

Main Results:

• The review synthesizes data on the safety and comparative effectiveness of IA chemotherapy.
• Identifies benefits and drawbacks of IA drug delivery for malignant gliomas.
• Highlights the potential for IA delivery to target specific tumor cell populations.

Conclusions:

• IA chemotherapy presents a potential treatment modality for malignant gliomas, with ongoing debate regarding its superiority.
• Targeted IA delivery may offer advantages in reaching specific tumor microenvironments.
• Further research is warranted to validate the hypothesis of targeting cancer stem cells via IA delivery.